PTH and chronic kidney disease: A recent study in 9303 incident hemodialysis patients including 3214 African Americans by Wolf and colleagues(16) suggested that therapy with activate vitamin D may be a potential explanation for racial survival differences in incident hemodialysis patients, especially since African-American CKD patients, by virtue of having higher PTH levels, are more likely to receive injectable vitamin D compounds in dialysis clinics.